Datascope Corp.

Form 483 issued January 21, 2022 · Wayne, New Jersey

Inspection
Nov 1, 2021 – Jan 21, 2022
Observations
13
Pages
15
FEI number
3007965489

In short: On January 21, 2022, FDA issued a Form 483 with 13 observations to Datascope Corp. in Wayne, New Jersey (FEI 3007965489) after an inspection that ran Nov 1, 2021 – Jan 21, 2022. The investigators were Claire L. Hambright and Colin E. Tack. Most observations concern cAPA and design controls; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

CAPA and design controls account for 10 of 13 observations.

CAPA6
Design controls4
Production & process controls3

Most cited: 21 CFR 820.30(g) (2×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures for corrective and preventive action…

  2. 02

    Risk analysis was not…

  3. 03

    Procedures for design validation…

  4. 04

    Procedures for design verification…

9 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Datascope Corp.?

FDA listed 13 observations on this Form 483, mostly about cAPA, design controls and production & process controls. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Datascope Corp.?

Claire L. Hambright and Colin E. Tack are named on this Form 483, for the inspection of Nov 1, 2021 – Jan 21, 2022. Each investigator has a profile showing what they cite most.

When was Datascope Corp. inspected by FDA?

The inspection ran Nov 1, 2021 – Jan 21, 2022, and the Form 483 is dated January 21, 2022.

How do I get the full Form 483 for Datascope Corp.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free